Back to Journals » Clinical Ophthalmology » Volume 15
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,182 | Dovepress* | 4,740+ | 364 | 5,104 | |
PubMed Central* | 442 | 159 | 601 | ||
Totals | 5,182 | 523 | 5,705 | ||
*Since 13 July 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar